Laobaixing Pharmacy Chain (LBX Pharmacy), a Chinese retail pharmacy chain backed by EQT Partners, closed up 44% on its price on the first day of trading in Shanghai.
Greater China | 24 Apr 2015 |
GIC Private, China Renaissance Capital Investment (CRCI) and GL Capital Group are among 26 investors subscribing to a HK$5 billion ($645 million) share placement by China Traditional Chinese Medicine (China TCM), intended to generate capital for acquisitions.
Expansion | 22 Apr 2015 |
Australian life sciences-focused VC firm Brandon Capital has reached a A$200 million ($154 million) final close on its latest vehicle - the Medical Research Commercialisation Fund 3 (MRCF 3).
Australasia | 21 Apr 2015 |
Singapore state-backed investment group Temasek Holdings has invested INR9.45 billion ($151 million) in India's Glenmark Pharma via a preferential allotment of shares.
South Asia | 20 Apr 2015 |
Hony Capital has sold HK$9.78 billion ($1.26 billion) worth of shares in CSPC Pharmaceutical to complete its exit from the Hong Kong-listed Chinese drug manufacturer.
Exits | 17 Apr 2015 |
Alibaba Group plans to inject the operations of its online pharmacy business into Alibaba Health Information Technology (Alibaba Health), a Hong Kong-listed healthcare company that it bought alongside Yungfeng Capital last year, in a deal worth HK$19.4...
Greater China | 15 Apr 2015 |
TVM Capital Life Science has reached a first close of $50 million on its debut China fund, which will invest in Western companies with a view to obtaining licenses for development and commercialization in China.
Healthcare | 14 Apr 2015 |
Warburg Pincus has exited its entire 27% stake in Indian healthcare chain Metropolis to the Shah family, one of the company's promoters. KKR backed the Shah family's buyback.
Healthcare | 10 Apr 2015 |
Johnson & Johnson Innovation (JJDC) - the venture capital arm of the eponymous healthcare and consumer goods multinational - has committed to $15 million to Vivo Capital's latest US and China-focused healthcare fund.
Fundraising | 08 Apr 2015 |
Meinian Onehealth Healthcare Group, the largest private provider of preventive healthcare check-up services in China and a portfolio company of The Carlyle Group among others, plans to list in Shenzhen through a reverse merger with Jiangsu Sanyou Group.
Greater China | 30 Mar 2015 |
Healthcare-focused Vivo Capital has attracted increasing attention from LPs for its hybrid focus on the US and China. As testament to this, its latest fund - Vivo Capital Fund VIII - closed at $750 million after nine months in the market, with demand...
Greater China | 25 Mar 2015
Megakaryon, a Japan-based stem cell technology developer, has raised JPY2.54 billion ($21.2 million) from a consortium of investors including existing backers Innovation Network Corporation of Japan (INCJ), Mitsubishi UFJ Capital, SMBC Venture Capital...
North Asia | 25 Mar 2015 |
US-based Vivo Capital has closed its eighth fund at $750 million. It will invest in healthcare companies in the US and China.
Venture | 19 Mar 2015 |
Hong Kong-based seed investor Nest has appointed Peter Dingle, formerly of Intel Corporation, to lead its newly-established Branded Accelerators program.
People | 18 Mar 2015 |
Updating your subscription status
The AVCJ Forum is the leading private equity and venture capital event in Asia. For 28 consecutive years, the AVCJ Forum has been the chosen platform where private equity's leading figures share their views on the Global and Asian market, debate their predictions and set the trends that shape the future of investments in the industry. Attended by a thousand senior delegates, the AVCJ Forum is the center of a weeklong ecosystem of investor meetings, VIP dinners and other high-level networking events that are supported by the biggest and most influential firms in the alternative assets industry.
These are important times for the private equity industry. General partners are becoming a more important and influential force in the global markets. With the diversification into other classes of the alternative space, private equity firms are cornering the market for private market investing by offering companies customized solutions for their financing needs. Traditional private equity firms have also upped their game with a renewed focus on operational value-add. Also back on the top are venture capitalists as they fuel the skyrocketing of the technology company valuations. Meanwhile, the Limited Partners community is also evolving with many positioning themselves as co-investment partners and branching out into direct investments while others continue to play the passive traditional LP role.
The AVCJ Forum will discuss all of the above and more. Don't miss the opportunity to keep abreast of all the crucial changes and developments in private equity and take part in the high level discussions that will create the outlook for the industry's future.
3-5 November 2015, Four Seasons Hotel, Hong Kong